Thus, in the presence of a pro-inflammatory molecule that resembles an obesity condition, the action of insulin sensitizers can re-establish the expression of molecules to improve insulin signaling in endometrial cells. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.